facebook
twitter
rss
account
search
search
 

Eli Lilly may drop inhaled insulin plan

March 8, 2008 at 12:01 PM   |   Comments

CAMBRIDGE, Mass., March 8 (UPI) -- Eli Lilly and Co. has pulled the plug on a collaboration with a Massachusetts company to develop inhaled insulin for diabetics.

Alkermes Inc. said it received a letter Friday from Lilly terminating the development and license agreement for AIR Inhaled Insulin. The announcement was made shortly after Alkermes released a statement that Lilly was evaluating its business case for the drug.

AIR Insulin is being evaluated in a broad phase-3 clinical trial program with patients with type 1 and type 2 diabetes. Alkermes said it was not aware of any safety, efficacy or manufacturing issues that would lead to the termination of the agreement.

Topics: Eli Lilly
© 2008 United Press International, Inc. All Rights Reserved. Any reproduction, republication, redistribution and/or modification of any UPI content is expressly prohibited without UPI's prior written consent.
Recommended UPI Stories
Featured UPI Collection
trending
Celebrity Couples of 2014 [PHOTOS]

Celebrity Couples of 2014 [PHOTOS]

Most Popular
1
Southwest U.S. could face 35-year 'megadrought'
2
Hurricane Katrina nine years later
3
Apple reportedly delays launch of rumored iWatch
4
New space debris monitoring facility set for Australia
5
Poacht follows dating app model to match job seekers with careers
Trending News
Video
x
Feedback